Sugi Predict

Sugi Predict / Compounds / SCHEMBL5484809

SCHEMBL5484809

SCHEMBL5484809

NC(CC(=O)O)(CC(=O)O)C(N)(CC(=O)O)CC(=O)O.[KH].[KH].[KH].[KH]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ HMGCR P04035 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ TBXA2R P21731 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ CYP2C19 P33261 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ GLRA1 P23415 1/20 0.39
▸ SLC6A9 P48067 1/20 0.39
▸ OR51E2 Q9H255 1/20 0.39
▸ CPT2 P23786 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ FFAR1 O14842 1/20 0.36
▸ ACLY P53396 3/20 0.35
▸ LDHA P00338 1/20 0.33
▸ SRR Q9GZT4 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5571319 1.00 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL1246171 1.00 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL702412 1.00 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Water SCHEMBL4654334 0.97 ALDH1A1 (0.41) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL26361 0.97 ALDH1A1 (0.45) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL17102799 0.93 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Ammonia Solution, Strong SCHEMBL8530807 0.93 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL20553189 0.93 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL22534095 0.93 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL3796605 0.93 ALDH1A1 (0.43) ALDH1A1HMGCRCHRM1TBXA2RADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190276728-A1 COMPOSITIONS AND METHODS FOR FILTER CAKE REMOVAL ETHICAL SOLUTIONS, LLC (US) 2019-09-12 — — US claimed
US-10308860-B2 Compositions and methods for filter cake removal ETHICAL SOLUTIONS LLC (US) 2019-06-04 — — US claimed
US-20190100687-A1 METHODS AND COMPOSITIONS FOR FILTER CAKE REMOVAL ETHICAL SOLUTIONS, LLC 2019-04-04 — — US claimed
US-20160362596-A1 COMPOSITIONS AND METHODS FOR FILTER CAKE REMOVAL ETHICAL SOLUTIONS, LLC 2016-12-15 — — US claimed
US-20140332212-A1 COMPOSITIONS AND METHODS FOR ENHANCED HYDROCARBON RECOVERY VERUTEK TECHNOLOGIES, INC. (US) 2014-11-13 — — US claimed
US-8679537-B2 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive Actamaz Surgical Materials, LLC (US) 2014-03-25 — — US claimed
US-8679536-B2 Aldol-crosslinked polymeric hydrogel adhesives ACTAMAX SURGICAL MATERIALS, LLC (US) 2014-03-25 — — US claimed
WO-2013081609-A1 COMPOSITIONS AND METHODS FOR ENHANCED HYDROCARBON RECOVERY VERUTEK TECHNOLOGIES, INC. (US) 2013-06-06 — — WO claimed
US-20070048337-A1 Aldol-crosslinked polymeric hydrogel adhesives ACTAMAX SURGICAL MATERIALS, LLC 2007-03-01 — — US claimed
US-20070048251-A1 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive ACTAMAX SURGICAL MATERIALS, LLC 2007-03-01 — — US claimed
US-11420181-B2 Methods for suppression of ammonia formation from staphylococcus-xylosus and staphylococcus-cohnii DOW GLOBAL TECHNOLOGIES LLC (US) 2022-08-23 — — US disclosed
US-20210274744-A1 METHODS AND COMPOSITION FOR SUPPRESSION OF AMMONIA FORMATION DOW GLOBAL TECHNOLOGIES LLC (US) 2021-09-09 — — US disclosed
CN-113018259-A Eye drops containing diquafosol 参天制药株式会社 2021-06-25 — — CN disclosed
US-20190276728-A1 COMPOSITIONS AND METHODS FOR FILTER CAKE REMOVAL ETHICAL SOLUTIONS, LLC (US) 2019-09-12 — — US disclosed
US-20190254251-A1 METHODS FOR SUPPRESSION OF AMMONIA FORMATION FROM STAPHYLOCOCCUS-XYLOSUS AND STAPHYLOCOCCUS-COHNII DOW GLOBAL TECHNOLOGIES LLC 2019-08-22 — — US disclosed
US-20070048337-A1 Aldol-crosslinked polymeric hydrogel adhesives ACTAMAX SURGICAL MATERIALS, LLC 2007-03-01 — — US disclosed
US-20060111265-A1 Acidic hard surface cleaners RECKITT BENCKISER INC. MORRIS CORPORATE CENTER IV (US) 2006-05-25 — — US disclosed
EP-1523545-A1 HARD SURFACE CLEANERS Reckitt Benckiser Inc. (US) 2005-04-20 — — EP disclosed
WO-2004009754-A1 ACIDIC HARD SURFACE CLEANERS RECKITT BENCKISER INC (US) 2004-01-29 — — WO disclosed
EP-0280238-A2 Silver halide color photographic photosensitive materials Fuji Photo Film Co., Ltd. (JP) 1988-08-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070048337-A1 Aldol-crosslinked polymeric hydrogel adhesives ALDOA, ADSL, ALDH1A2 ALDH1A1 9/4885HMGCR 417/4885CHRM1 1711/4885
US-20070048251-A1 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive SI, ADSL, AOX1 ALDH1A1 27/4885HMGCR 315/4885CHRM1 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.